Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy MEDNAX (MD) stocks in Canada
Learn how to easily invest in MEDNAX stocks.
MEDNAX is a medical care facilities business based in the US. MEDNAX stocks (MD.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $29.21 – a decrease of 7.06% over the previous week. MEDNAX employs 5,600 staff and has a trailing 12-month revenue of around $1.8 billion.
How to buy shares in MEDNAX
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in MEDNAX?
- Has coronavirus impacted MEDNAX shares?
- MEDNAX shares summary
- Compare share dealing platforms
- Is MEDNAX stock a buy or sell?
- MEDNAX performance over time
- Is MEDNAX suitable for ethical investing?
- Are MEDNAX shares over-valued?
- MEDNAX's financials
- How volatile are MEDNAX shares?
- Does MEDNAX pay a dividend?
- Have MEDNAX shares ever split?
- Other common questions
MEDNAX stock price (NYSE:MD)Use our graph to track the performance of MD stocks over time.
MEDNAX shares at a glance
|Latest market close||$25.01|
|52-week range||$20.27 - $35.67|
|50-day moving average||$26.65|
|200-day moving average||$28.83|
|Wall St. target price||$27.10|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.23|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy MEDNAX stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
MEDNAX price performance over time
|1 week (2022-01-11)||-7.23%|
|1 month (2021-12-17)||N/A|
|3 months (2021-10-20)||-6.12%|
|6 months (2021-07-21)||-15.39%|
|1 year (2021-01-21)||2.12%|
|2 years (2020-01-21)||-7.85%|
|3 years (2019-01-18)||36.79|
|5 years (2017-01-20)||70.05|
Is MEDNAX under- or over-valued?
Valuing MEDNAX stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MEDNAX's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MEDNAX's P/E ratio
MEDNAX's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 116x. In other words, MEDNAX shares trade at around 116x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
MEDNAX's PEG ratio
MEDNAX's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.88. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MEDNAX's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MEDNAX's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $223.9 million.
The EBITDA is a measure of a MEDNAX's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.8 billion|
|Operating margin TTM||10.49%|
|Gross profit TTM||$449.3 million|
|Return on assets TTM||3.95%|
|Return on equity TTM||8.75%|
|Market capitalisation||$2.3 billion|
TTM: trailing 12 months
MEDNAX's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like MEDNAX.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
MEDNAX's total ESG risk score
Total ESG risk: 19.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and MEDNAX's overall score of 19.73 (as at 01/01/2019) is pretty good – landing it in it in the 22nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like MEDNAX is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
MEDNAX's environmental score
Environmental score: 1.84/100
MEDNAX's environmental score of 1.84 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that MEDNAX is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
MEDNAX's social score
Social score: 8.57/100
MEDNAX's social score of 8.57 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that MEDNAX is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
MEDNAX's governance score
Governance score: 5.5/100
MEDNAX's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that MEDNAX is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
MEDNAX's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. MEDNAX scored a 1 out of 5 for controversy – the highest score possible, reflecting that MEDNAX has managed to keep its nose clean.
MEDNAX share dividends
We're not expecting MEDNAX to pay a dividend over the next 12 months.
Have MEDNAX's shares ever split?
MEDNAX's shares were split on a 2:1 basis on 20 December 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your MEDNAX shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for MEDNAX shares which in turn could have impacted MEDNAX's share price.
MEDNAX share price volatility
Over the last 12 months, MEDNAX's shares have ranged in value from as little as $20.2701 up to $35.67. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MEDNAX's is 2.1049. This would suggest that MEDNAX's shares are significantly more volatile than the average for this exchange and represent a higher risk.
MEDNAX, Inc. , together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of March 16, 2021, it operated a network of approximately 2,300 physicians.
Stocks similar to MEDNAX
MEDNAX in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Here's Why Seasoned Investors are Retaining Mednax (MD)
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.